← Back to Directory

Sustained Release Melatonin

Time-Release Melatonin, Extended-Release Melatonin, Prolonged-Release Melatonin

Visual ViewRaw Data

Meta Information

ID:sustained-release-melatonin
Name:Sustained Release Melatonin
Schema Version:1.5

Alternate Names

  • Time-Release Melatonin
  • Extended-Release Melatonin
  • Prolonged-Release Melatonin

Active Compound

melatonin

Intervention Type

therapeutic_agent

Delivery

Route:
oral
Scope:
  • systemic

Regulatory Status

  • us:dietary_supplement
  • eu:rx_drug
  • uk:rx_drug
  • ca:natural_health_product

Indication

Focus:
  • symptom_management
  • healthspan
Description:
Primarily used to improve sleep maintenance and regulate circadian rhythms, which are crucial for cellular repair and overall healthspan.

Typical Protocol

  • Take 1-5 mg approximately 1-2 hours before desired bedtime to allow for initial absorption.
  • This formulation is designed to maintain sleep, not initiate it, by releasing melatonin over 6-8 hours.
  • Use the lowest effective dose to minimize potential for morning grogginess or tolerance.

Expected Cost Mean

Low Cost:
10
High Cost:
30
Cost Type:
monthly
Description:
Widely available as an over-the-counter supplement; not typically covered by insurance.

Summary

Melatonin is a neurohormone that governs the sleep-wake cycle. Sustained-release formulations are engineered to mimic the body's natural nocturnal secretion profile, releasing the hormone over several hours to help maintain sleep. By improving sleep quality and duration, it supports critical restorative processes like autophagy, DNA repair, and glymphatic clearance, which are fundamental to healthspan.

Purpose

Supports sleep maintenance and circadian rhythm for enhanced cellular repair.

Card Summary

A sustained-release hormone formulation designed to improve sleep maintenance and support restorative biological processes.

Drug Class

melatonin_receptor_agonist

Drugs In Class

Empty Array

Impact

Score:
5.5
Justification:
Improves sleep quality, a key pillar of healthspan, but direct longevity effects are unproven.

Evidence

Grade:
A
Score:
8.5
Justification:
Multiple human RCTs confirm efficacy for improving sleep quality, especially in older adults.

Safety

Score:
3
Justification:
Generally well-tolerated with a low side effect profile; long-term safety data is limited.

Flags

  • Sustained-release is for sleep *maintenance*; immediate-release is for sleep *onset*.
  • Can cause next-day grogginess or vivid dreams, especially at higher doses.
  • May interact with blood thinners, immunosuppressants, and diabetes medications.
  • Avoid in individuals with autoimmune diseases unless cleared by a physician.
  • Long-term effects on endogenous melatonin production are not fully understood.

Verdict

A valuable tool for improving sleep maintenance, a cornerstone of health.

Created

2026-06-12T17:48:23.749392Z

Ai Model

Gemini 2.5 Pro (High)